06/15/2026
Big changes may be coming for older adults and obesity treatment access.
Medicare is beginning to expand access to GLP-1 medications for certain patients with obesity and related health conditions through new pilot programs rolling out this year.
What’s especially important:
-This signals a major shift in how obesity is being viewed medically- not just as weight, but as a chronic disease tied to conditions like sleep apnea, cardiovascular disease, kidney disease, and metabolic health.
-At the same time, the approval process is still nuanced, with different eligibility pathways, insurance rules, and medical criteria depending on the patient.
This is exactly why individualized care matters. The landscape is changing quickly, and helping patients understand their options is becoming just as important as the medications themselves.